Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development

A physical model approach to the topical delivery of a vidarabine ester prodrug was investigated. It involved modeling, theoretical simulations, experimental method development for factoring and quantifying parameters, and, finally, employment of the deduced parameters to determine the steady-state...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences Vol. 68; no. 11; p. 1341
Main Authors: Yu, C D, Fox, J L, Ho, N F, Higuchi, W I
Format: Journal Article
Language:English
Published: United States 01-11-1979
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract A physical model approach to the topical delivery of a vidarabine ester prodrug was investigated. It involved modeling, theoretical simulations, experimental method development for factoring and quantifying parameters, and, finally, employment of the deduced parameters to determine the steady-state species fluxes and concentration profiles in the target tissue. The present report describes the physical modeling and theoretical simulation aspects. The physical model for the simultaneous transport and bioconversion of a topically delivered prodrug was formulated assuming homogeneous enzyme distributions and constant diffusivities in the membrane. The mathematical problem was solved, and the solution yielded concentration profiles and fluxes of all species in the biomembrane. These results provided the prevailing levels of the prodrug, the drug, and the metabolite at the target site and the transport rates of all species into the bloodstream. Computations of concentration profiles and fluxes were carried out for a reasonable range of the parameters. The relative activities of the esterase and the deaminase enzymes, as well as the stratum corneum permeabilities, were important in influencing the concentration profiles and fluxes of all species.
AbstractList A physical model approach to the topical delivery of a vidarabine ester prodrug was investigated. It involved modeling, theoretical simulations, experimental method development for factoring and quantifying parameters, and, finally, employment of the deduced parameters to determine the steady-state species fluxes and concentration profiles in the target tissue. The present report describes the physical modeling and theoretical simulation aspects. The physical model for the simultaneous transport and bioconversion of a topically delivered prodrug was formulated assuming homogeneous enzyme distributions and constant diffusivities in the membrane. The mathematical problem was solved, and the solution yielded concentration profiles and fluxes of all species in the biomembrane. These results provided the prevailing levels of the prodrug, the drug, and the metabolite at the target site and the transport rates of all species into the bloodstream. Computations of concentration profiles and fluxes were carried out for a reasonable range of the parameters. The relative activities of the esterase and the deaminase enzymes, as well as the stratum corneum permeabilities, were important in influencing the concentration profiles and fluxes of all species.
Author Yu, C D
Higuchi, W I
Fox, J L
Ho, N F
Author_xml – sequence: 1
  givenname: C D
  surname: Yu
  fullname: Yu, C D
– sequence: 2
  givenname: J L
  surname: Fox
  fullname: Fox, J L
– sequence: 3
  givenname: N F
  surname: Ho
  fullname: Ho, N F
– sequence: 4
  givenname: W I
  surname: Higuchi
  fullname: Higuchi, W I
BackLink https://www.ncbi.nlm.nih.gov/pubmed/512880$$D View this record in MEDLINE/PubMed
BookMark eNpdkD1PwzAYhD2Uj7awMjF4Y0qxHduJ2VDFR6VKMMBcOfEbcJXYke1E6h_h9xLRTkwn3Z2ek26BZs47QOiGkhUlhN3v-7hikhBZUkr4DM0nk2W54OoSLWLckykiQlygc0FZWZI5-nn_PkRb6xZ33kCLYdTtoJP1DvsGJ9__ZX3wJgxfeGrYEcIhi7Yb2qQd-CHiFLSLvQ8Ja2dwZX3t3dSKJ8hojQ66sg4ycZdNfAg6Ad484H_bBkZofd-BS1forNFthOuTLtHn89PH-jXbvr1s1o_brM455ZlRVS6kkFCWGjRlhQCoFWeiyJnkVDZCKWhqTkVTNXmlmlxqplhBOSkk45wt0e2R2w9VB2bXB9vpcNgd72G_2WpqMQ
CitedBy_id crossref_primary_10_1002_jps_21594
crossref_primary_10_1016_0378_5173_89_90270_6
crossref_primary_10_1016_j_jconrel_2004_03_020
crossref_primary_10_1016_0168_3659_87_90059_9
crossref_primary_10_1016_0378_5173_93_90405_5
crossref_primary_10_1016_0378_5173_83_90145_X
crossref_primary_10_3109_03602539009041089
crossref_primary_10_1002_jps_2600720620
crossref_primary_10_1016_j_addr_2012_10_009
crossref_primary_10_1002_jps_2600750104
crossref_primary_10_1016_0378_5173_88_90055_5
crossref_primary_10_1016_0378_5173_86_90179_1
crossref_primary_10_1081_CUS_120001859
crossref_primary_10_1002_jps_2600841215
crossref_primary_10_1007_s11095_006_9781_z
crossref_primary_10_1016_S0928_0987_97_00068_7
crossref_primary_10_3109_03639049409038326
crossref_primary_10_3109_00498258709043943
crossref_primary_10_1016_0168_3659_94_00101_Y
crossref_primary_10_1016_0378_5173_94_90297_6
crossref_primary_10_1002_jps_2600810112
crossref_primary_10_1016_j_jconrel_2006_04_003
crossref_primary_10_1016_0168_3659_87_90009_5
crossref_primary_10_1016_S0022_5193_89_80174_2
crossref_primary_10_1016_0378_5173_85_90107_3
crossref_primary_10_1007_BF03190197
crossref_primary_10_1007_s11095_005_4593_0
crossref_primary_10_1159_000351926
crossref_primary_10_1016_S0939_6411_97_00060_X
crossref_primary_10_1002_jps_10239
crossref_primary_10_1002_jps_2600681105
crossref_primary_10_1016_S0169_409X_03_00118_2
crossref_primary_10_1016_j_ajps_2017_01_005
crossref_primary_10_1111_j_2042_7158_1994_tb03251_x
crossref_primary_10_1016_0168_3659_85_90037_9
crossref_primary_10_1016_0378_5173_94_90245_3
crossref_primary_10_1016_0025_5564_93_90048_F
crossref_primary_10_1002_jps_2600841114
crossref_primary_10_1016_0378_5173_90_90142_Q
crossref_primary_10_1016_0378_5173_90_90174_3
crossref_primary_10_1016_0378_5173_87_90194_3
crossref_primary_10_1016_j_ijpharm_2017_04_030
crossref_primary_10_1016_0168_3659_87_90067_8
crossref_primary_10_1016_0378_5173_82_90048_5
crossref_primary_10_1002_jps_2600750221
crossref_primary_10_1016_0378_5173_90_90184_6
crossref_primary_10_1002_jps_2600731120
crossref_primary_10_1002_jps_2600690708
crossref_primary_10_1002_jps_2600690707
crossref_primary_10_1006_jtbi_2000_2023
crossref_primary_10_1111_1523_1747_ep12277361
crossref_primary_10_1007_BF01061849
crossref_primary_10_1002_jps_2600730706
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1002/jps.2600681104
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
Mathematics
ExternalDocumentID 512880
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OB
1OC
1ZS
31~
33P
36B
3O-
3WU
4.4
457
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
A8Z
AAEVG
AAHHS
AAKUH
AALRI
AAOIN
AAONW
AAXUO
AAYOK
AAZKR
ABCQN
ABEML
ABFRF
ABIJN
ABJNI
ABMAC
ABOCM
ABPVW
ACBWZ
ACCFJ
ACGFO
ACGFS
ACIWK
ACPRK
ACSCC
ACXQS
ADBBV
ADIZJ
ADVLN
AEEZP
AEFWE
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFJKZ
AFRAH
AFTJW
AFZJQ
AGHFR
AI.
AITUG
AIWBW
AJAOE
AJBDE
AKRWK
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
AMRAJ
ATUGU
AZBYB
BAFTC
BDRZF
BNHUX
BROTX
BRXPI
BY8
CGR
CS3
CUY
CVF
D-E
D-F
DCZOG
DPXWK
DR2
DU5
E3Z
EBD
EBS
ECM
EIF
EJD
EMB
EMOBN
ESTFP
F00
F01
F04
F5P
FDB
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HHY
HHZ
HOLLA
HVGLF
HX~
HZ~
IX1
J0M
JPC
KQQ
L7B
LAW
LC2
LC3
LH4
LP6
LP7
LSO
LW6
M41
M6Q
MK0
MK4
N04
N05
N9A
NF~
NNB
NPM
O66
O9-
OIG
P2P
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SSZ
SUPJJ
SV3
UB1
UKR
UNMZH
V2E
V8K
VH1
W8V
W99
WBFHL
WH7
WIB
WJL
WQJ
WRC
WUP
WWP
WYUIH
XG1
XPP
XV2
Y6R
YCJ
ZE2
ZGI
ZXP
~IA
~WT
ID FETCH-LOGICAL-c3414-d9b35656e88aea1275eec94257326416f599efc415fbf3b9f36a2927140762442
ISSN 0022-3549
IngestDate Sat Sep 28 08:38:19 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3414-d9b35656e88aea1275eec94257326416f599efc415fbf3b9f36a2927140762442
PMID 512880
ParticipantIDs pubmed_primary_512880
PublicationCentury 1900
PublicationDate November 1979
PublicationDateYYYYMMDD 1979-11-01
PublicationDate_xml – month: 11
  year: 1979
  text: November 1979
PublicationDecade 1970
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of pharmaceutical sciences
PublicationTitleAlternate J Pharm Sci
PublicationYear 1979
SSID ssj0006055
Score 1.3844247
Snippet A physical model approach to the topical delivery of a vidarabine ester prodrug was investigated. It involved modeling, theoretical simulations, experimental...
SourceID pubmed
SourceType Index Database
StartPage 1341
SubjectTerms Administration, Topical
Animals
Biological Transport
In Vitro Techniques
Mathematics
Mice
Mice, Nude
Models, Biological
Skin - ultrastructure
Skin Absorption
Valerates - metabolism
Vidarabine - administration & dosage
Vidarabine - analogs & derivatives
Vidarabine - metabolism
Title Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate I: Physical model development
URI https://www.ncbi.nlm.nih.gov/pubmed/512880
Volume 68
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxELUS4NAeEJQiWgryAdpDaprsR2L3hkpQitQqUoMEp8q7tksqNVl1G6T8EX4vM7Z3vYlaBAcuq5W9sjc7T-OZycwbQt7FXdU1KhMsVlnCEiMM49lAMh3nGfg9xiQ2N2d0MTj_xj8Nk2GrVTUtDWP_VdIwBrLGytl_kHa9KAzAPcgcriB1uP6V3MfVh7c9bhps3jYbYF7YOVSbt4urDjyBeRlLVk4xs1DONGbE3lWE5_afhWw6t6npNq6Gi_ycKnkrwaPWLH0fDRjsgMzMunOK4YW1_VVISnrADi5-rETV_ZFcm_rfFzaWGzKT_Xn5pRPC5jbcex6SlEfTK-zxYvMHfVhYuUq_gfAVfg1lbQsNHKNppaz7vAnKXkP1IjPdvWeC45i9LsoPSMbf5z3f8LgBhuLGogGMH-76Sv1pbo2f2020SRtsLTTHT85qSwBcxbRmq4cfUpGGdqOj1dfZIE_cMmvOjTVyJs_IUy8V-tHB6jlp6dkW2TyrqX3LLbI_dvJaHtJJqN0rD-k-HQca9OUL8qtCArVIoAGJdG6oRyL1SKT3IpHWSKSARLqCRFykicSDGof09Jiu7d1A4Tb5-nk4ORkx3wWE5SDRhCmRxeh1aM6lltiPQOtc4FEDnge4EyYVQpscDFGTmTgTJu7LSERIRAkHfZJEL8mj2XymXxHKUylTrVQ3lTrR4Hj3o1wjg5-Je3Ev5ztk2339y8JRvVw6qew-MP6abATg7pHHBnSIfkPapVq8tUj4DYXQl2s
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Physical+model+evaluation+of+topical+prodrug+delivery-simultaneous+transport+and+bioconversion+of+vidarabine-5%27-valerate+I%3A+Physical+model+development&rft.jtitle=Journal+of+pharmaceutical+sciences&rft.au=Yu%2C+C+D&rft.au=Fox%2C+J+L&rft.au=Ho%2C+N+F&rft.au=Higuchi%2C+W+I&rft.date=1979-11-01&rft.issn=0022-3549&rft.volume=68&rft.issue=11&rft.spage=1341&rft_id=info:doi/10.1002%2Fjps.2600681104&rft_id=info%3Apmid%2F512880&rft_id=info%3Apmid%2F512880&rft.externalDocID=512880
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3549&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3549&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3549&client=summon